Tier 2 — strong
Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Drugs
2023
83(5):403-427
Bibliography
- PubMed
- PMID 36941490
- Funding
- Funding was not established from the accessible source; this is not a declaration of no funding.
- Competing interests
- A complete competing-interest declaration was not available in the accessible source; no absence of conflicts is inferred.
Study snapshot
| Design | Systematic review and meta-analysis |
|---|---|
| Model | Published human studies |
| Sample | 18 studies; 1788 participants |
| Intervention | Evidence synthesis; interventions and comparators vary across included studies |
| Duration | No new treatment; included-study durations vary |
| Endpoints | Pooled clinical or metabolic outcomes; Risk of bias and heterogeneity; Adverse-event reporting |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
- Berberine for Menopause Weight Gain: What Evidence Applies?Berberine for menopause weight gain: distinguish mixed-adult evidence, female lipid trials, blend claims, metabolic goals, dosing limits and safety.Read analysis
- Berberine for Cholesterol: LDL, ApoB and Triglyceride EvidenceBerberine for cholesterol explained: LDL, triglycerides, apoB, 2026 sex-specific findings, statin questions, study limitations and product selection.Read analysis
- Berberine Dosage: Study Doses, Capsule Strengths and SafetyCompare berberine study doses for glucose, weight and lipids. Understand 500 mg capsules, formulation differences, dose limits, duration and safety.Read analysis
- Berberine Benefits: What Human Studies Actually ShowExplore berberine benefits for blood sugar, cholesterol, weight and gut health, with human trial results, 2026 updates, safety and formulation differences.Read analysis
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
